Development of a Rhenium-186-Labeled MAG3-Conjugated Bisphosphonate for the Palliation of Metastatic Bone Pain Based on the Concept of Bifunctional Radiopharmaceuticals-Reference-Cited by-同舟云学术

Development of a Rhenium-186-Labeled MAG3-Conjugated Bisphosphonate for the Palliation of Metastatic Bone Pain Based on the Concept of Bifunctional Radiopharmaceuticals

Published:2005-07-01 Issue:4 Volume:16 Page:751-757
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Ogawa Kazuma¹,Mukai Takahiro¹,Arano Yasushi¹,Ono Masahiro¹,Hanaoka Hirofumi¹,Ishino Seigo¹,Hashimoto Kazuyuki¹,Nishimura Hiroshi¹,Saji Hideo¹

Affiliation:

1. Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan, Central Institute of Radioisotopes Science, Division of Tracer Kinetics, Advanced Science Research Center, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Japan, Radioisotope Laboratory, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-0841, Japan, Department of Biomolecular Recognition Chemistry,...

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc040249w

Reference22 articles.

1. Osteolytic bone metastasis in breast cancer

2. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alendronate conjugate for targeted delivery to bone-forming prostate cancer;Talanta;2023-05

2. Alendronate Conjugate for Targeted Delivery to Bone-Forming Prostate Cancer;2022-09-27

3. Bifunctional chelators for radiorhenium: past, present and future outlook;RSC Medicinal Chemistry;2022

4. Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions;Current Medicinal Chemistry;2020-06-04

5. Development of Diagnostic and Therapeutic Probes with Controlled Pharmacokinetics for Use in Radiotheranostics;Chemical and Pharmaceutical Bulletin;2019-09-01